Article info

Download PDFPDF

Potential therapies for immune-related adverse events associated with immune checkpoint inhibition: from monoclonal antibodies to kinase inhibition

Authors

  • Meagan-Helen Henderson Berg Division of Dermatology, McGill University, Montreal, Québec, CanadaDivision of Experimental Medicine, McGill University, Montreal, Québec, CanadaCancer Axis, Lady Davis Institute for Medical Research, Montreal, Québec, Canada PubMed articlesGoogle scholar articles
  • Sonia Victoria del Rincón Division of Experimental Medicine, McGill University, Montreal, Québec, CanadaCancer Axis, Lady Davis Institute for Medical Research, Montreal, Québec, CanadaDepartment of Oncology, Jewish General Hospital and McGill University, Montreal, Québec, CanadaCentre for Translational Research, McGill University, Montreal, Québec, Canada PubMed articlesGoogle scholar articles
  • Wilson H Miller Division of Experimental Medicine, McGill University, Montreal, Québec, CanadaCancer Axis, Lady Davis Institute for Medical Research, Montreal, Québec, CanadaDepartment of Oncology, Jewish General Hospital and McGill University, Montreal, Québec, CanadaCentre for Translational Research, McGill University, Montreal, Québec, CanadaRossy Cancer Network, McGill University, Montreal, Québec, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Wilson H Miller; wilsonmiller{at}gmail.com; Dr Sonia Victoria del Rincón; sonia.delrincon{at}mcgill.ca
View Full Text

Citation

Henderson Berg M, del Rincón SV, Miller WH
Potential therapies for immune-related adverse events associated with immune checkpoint inhibition: from monoclonal antibodies to kinase inhibition

Publication history

  • Accepted December 14, 2021
  • First published January 27, 2022.
Online issue publication 
January 27, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.